Medical School:
University of Missouri
Columbia School of Medicine
Columbia, Missouri
Internal Medicine Residency:
St John's Mercy Medical Center
St Louis, Missouri
Oncology-Hematology Fellowship:
Hematology and Oncology
University of Missouri
University of Missouri Medical Center
Columbia, Missouri
Board Certifications:
Internal Medicine
Medical Oncology
Dr. White is certified by the American Board of Internal Medicine and is a Diplomate of its Subspecialty Board of Medical Oncology. Dr. White is a Fellow in the American College of Physicians and a member of the American Society of Clinical Oncology, American Society of Hematology, and the St. Louis Society of Medical Oncology. Dr. White is a member with the Cancer and Leukemia Group B (CALGB), The National Surgical Adjuvant Breast and Bowel Project (NSABP) and The North Central Cancer Treatment Group (NCCTG). He is an Investigator for the Heartland Community Clinical Oncology Program (heartlandccop.com).
Dr. White has office hours at our St. Louis office located at 12855 N Forty Drive, Suite 200 and our Washington office located at 1351 Jefferson St., Suite 120.
Eckardt, J.R., Schmidt, A.M., Needles, B.M., Greco, A.O., White, L.A., Denes, A.E.: A Phase I study of combination of Docetaxel (D) and Gemcitabine (G). (Submitted). 1997
Publications:
Leonard A. White, Jr., Leonard H. Brubaker, Richard H. Aster, Patrick H. Henry, and Edward H. Adelstein: Platelet Satellitism and Phagocytosis by Neutrophils: Association with Antiplatelet Antibodies and Lymphoma. Am J. of Hematology A: 313-323, 1978
Leonard A. White, Jr., Michael C. Perry, Carl g. Kardinal, B.J., Kennedy, Raymond, B. Weiss, and Robert W. Carey: Phase II Study of 5-Fluorouracil, Methyl-CCNU, and Daunorubicin in Colorectal Cancer: A Cancer and Leukemia Group B Study. Cancer Treatment Reports Vol. 63, No. 2, Feb., 1979.
Leonard A. White, Jr., M.D.: Hormone Receptors and Hormone Therapy in Breast Cancer. RES Medica
Ellen R. Gaynor, Joseph M. Unger, Thomas P. Miller, Thomas M. Grogan, Leonard A. White, JR, Glenn M. Mills, Stanley P. Balcerzak, Mary Varterasian, Michael LeBlanc, and Richard I. Fisher: Infusional CHOP Chemostherapy (CVAD) with or without Chmeosensitizers Offers No Advantage Over Standard CHOP Therapy in the Treatment of Lymphoma: A Southwest Oncology Group Study. Journal of Clinical Oncology, Vol. 19, No 3 (February 15), 2001; p pp. 750-755
A.E. Denes, B.M. Needles, A.M. Schmidt, L.A. White, A.O. Greco, J.R.Eckardt: A comparison of Two Schedules of Docetaxel in Combination with Gemcitabine Given Every Other Week: American Society of Clinical Oncologists Proceeding, 2000
J. Eckardt, A. Schmidt, K. Martin, L. White, A. Greco, B. Needles: A Phase I Trial of Oral Topotecan in Combination with Oral Temozolomide with /and without G-CSF Daily Times 5 Every 28 Days: American Society of Clinical Oncologists Proceedings, 2001
